Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells

Journal of Proteome Research

Volumn 9, Issue 11, 2010, Pages 5668-5676

  Lee, Dong Hyeon ^a   Chung, Kwanghoe ^a   Song, Ji Ae ^a   Kim, Tae Heon ^a,b   Kang, Haeyoun ^b   Huh, Jin Hyong ^b   Jung, Sang Geun ^a   Ko, Jung Jae ^a   An, Hee Jung ^a,b  

^a CHA University   (South Korea)

^b CHA University   (South Korea)

Author keywords

biomarker; drug resistance; GDI2; hnRNP; ovarian cancer; paclitaxel; proteomics

Indexed keywords

ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKER; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; LIPOCORTIN 1; PACLITAXEL; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; COMPARATIVE STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; PROTEOMICS;

EID: 78149405526     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100478u     Document Type: Article

References (33)

1. Eltabbakh, G. H.; Awtrey, C. S. Expert Opin. Pharmacother. 2001, 2 (1) 109-124
2. Willmott, L. J.; Fruehauf, J. P. J. Oncol. 2010, 2010, 740472
3. Marupudi, N. I.; Han, J. E.; Li, K. W.; Renard, V. M.; Tyler, B. M.; Brem, H. Expert Opin. Drug Saf. 2007, 6 (5) 609-621
4. Stordal, B.; Pavlakis, N.; Davey, R. Cancer Treat. Rev. 2007, 33 (8) 688-703
5. Hartmann, L. C.; Lu, K. H.; Linete, G. P.; Cliby, W. A.; Kalli, K. R.; Gershenson, D.; Bast, R. C.; Stec, J.; Iartchouk, N.; Smith, D. I.; Ross, J. S.; Hoersch, S.; Shridhar, V.; Lillie, J.; Kaufmann, S. H.; Clark, E. A. A.; Damokosh, A. I. Clin. Cancer Res. 2005, 11, 2149-2155
6. Goto, T.; Takano, M.; Sakamoto, M.; Kondo, A.; Hirata, J.; Kita, T.; Tsuda, H.; Tenjin, Y.; Kikuchi, Y. Oncol. Rep. 2006, 15 (5) 1265-1271
7. Chung, K. H.; Lee, D. H.; Kim, Y.; Kim, T. H.; Huh, J. H.; Chung, S. G.; Lee, S.; Lee, C.; Ko, J. J.; An, H. J. J. Proteome Res. 2010, 9 (1) 451-457
8. Di Michele, M.; Della Corte., A.; Cicchillitti, L.; Del Boccio, P.; Urbani, A.; Ferlini, C.; Scambia, G.; Donati, M. B.; Rotilio, D. Biochim. Biophys. Acta 2009, 1794 (2) 225-236
9. Aggarwal, S.; He, T.; Fitzhugh, W.; Rosenthal, K.; Field, B.; Heidbrink, J.; Mesmer, D.; Ruben, S. M.; Moore, P. A. Gynecol. Oncol. 2009, 115 (3) 430-437
10. Le Moguen, K.; Lincet, H.; Deslandes, E.; Hubert-Roux, M.; Lange, C.; Poulain, L.; Gauduchon, P.; Baudin, B. Proteomics 2006, 6 (19) 5183-5192
11. Bahk, Y.; Kim, S.; Kim, J.; Euh, H.; Bai, G.; Cho, S.; Kim, Y. Proteomics 2004, 4, 3299-3307
12. Zuo, X.; Lynn Echan, L.; Hembach, P.; Tang, H. Y.; Kaye, D.; Speicher, K. D.; Santoli, D.; David, W.; Speicher, D. W. Electrophoresis 2001, 22, 1603-1615
13. Dennis, G., Jr.; Sherman, B. T.; Hosack, D. A. Genome Biol. 2003, 4, P3
14. Meani, F.; Pecorelli, S.; Liotta, L.; Petricoin, E. F. Mol. Diagn. Ther. 2009, 13 (5) 297-311
15. Cicchillitti, L.; Michele, D. M.; Urbani, A.; Ferlini., C.; Donati, M. B.; Scambia, G.; Rotilio, D. J. Proteome Res. 2009, 8 (4) 1902-1912
16. Michele, D. M.; Marcone, S.; Cicchillitti, L.; Corte, A. D.; Ferlini, C.; Scambia, G.; Donati, M. B.; Rotilio, D. J. Proteomics 2010, 73 (5) 879-898
17. Pan, S.; Cheng, L.; White, J. T.; Lu, W.; Utleg, A. G.; Yan, X.; Urban, N. D.; Drescher, C. W.; Hood, L.; Lin, B. OMICS 2009, 13 (4) 345-354
18. Levi, B. P.; Yilmaz, O. H.; Duester, G.; Morrison, S. J. Blood 2009, 113, 1670-1680
19. Tanei, T.; Morimoto, K.; Shimazu, K.; Kim, S. J.; Tanji, Y.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Clin. Cancer Res. 2009, 15, 4234-4241
20. Gerke, V.; Moss, S. E. Physiol. Rev. 2002, 82, 331-371
21. Schlaepfer., D. D.; Haigler, H. T. J. Biol. Chem. 1990, 111, 229-238
22. Lim, L. H. K.; Pervaiz, S. FASEB J. 2007, 21, 968-975
23. Alldridge, L. C.; Bryant, C. E. Exp. Cell Res. 2003, 290, 93-107
24. Sinha, P.; Hutter, G.; Kottgen, E.; Dietel, M.; Schadendorf, D.; Lage, H. J. Biochem. Biiophys. Methods 1998, 37, 105-116
25. Chuthapisith, S.; Bean, B. E.; Cowley, G.; Eremin, J. M.; Samphao, S.; Layfield, R.; Kerr, I. D.; Wiseman, J.; EI-sheemy, M.; Sreenivasan, T.; Eremin, O. Eur. J. Cancer 2009, 45, 1274-1281
26. Kim, A.; Enomoto, T.; Serada, S.; Ueda, Y.; Takahashi, T.; Ripley, B.; Miyatake, T.; Fujita, M.; Lee, C. M.; Morimoto, K.; Fujimoto, M.; Kimura, T.; Naka, T. Int. J. Cancer 2009, 125, 2316-2322
27. Song, J.; Shih, I.; Salani, R.; Chan, D. W.; Zhang, Z. Clin. Cancer Res. 2007, 13, 6842-6849
28. Dreyfuss, G.; Matunis, M. J.; PinolRoma, S.; Burd, C. G. Annu. Rev. Biochem. 1993, 62, 289-321
29. Ford, L. P.; Wright, W. E.; Shay, J. W. Oncogene 2002, 21, 580-583
30. Zhou, J.; Nong, L.; Wloch, M.; Cantor, A.; Mulshine, J. L.; Tockman, M. S. Lung Cancer 2001, 34 (3) 341-350
31. DerMardirossian, C.; Bokoch, G. M. Trends Cell Biol. 2005, 15, 356-363
32. Tapper, J.; Kettunen, E.; EI-Rifai, W.; Seppala, M.; Andersson, L. C.; Knuutila, S. Cancer Genet. Cytogenet. 2001, 128, 1-6
33. Theodorescu, D.; Sapinoso, L. M.; Conaway, M. R.; Oxford, G.; Hampton, G. M.; Frierson, H. F. Clin. Cancer Res. 2004, 10, 3800-3806